Cancer Institute and Hospital, Chinese Academy of Medical Sciences: Neoplasms trials

The registry lists 16 Neoplasms studies with Cancer Institute and Hospital, Chinese Academy of Medical Sciences as lead sponsor. 13 are open to participants now and 1 have results posted.

Early Phase 1 3Phase 1 6Phase 2 7Phase 3 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Inhaled mRNA Immunotherapy for Patients With Advanced Lung Cancer or Pulmonary Metastatic Solid TumorsNot yet recruitingNCT07657611Early Phase 1
• Safety and Efficacy of Intravenous IDOV-Immune in Patients With Advanced Solid TumorsEnrolling by invitationNCT07656090Early Phase 1
• Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)RecruitingNCT07110090Phase 1
• Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to ImmunotherapyRecruitingNCT06490068Phase 2
• Clinical Trial of BT02 in Patients With Advanced Solid TumorsRecruitingNCT06404905Phase 1
• Personalized KSX01-TCRT in Patients With Advanced Solid TumorsRecruitingNCT06150365Early Phase 1
• 68Ga-TCR-FAPI PET/CT in Patients With Various Types of CancerRecruitingNCT06084767Not applicable
• A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor PatientsNot yet recruitingNCT06082570Phase 1/2
• A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor PatientsNot yet recruitingNCT06082557Phase 1/2
• NV-001 in the Treatment of Advanced Solid TumorsRecruitingNCT06051760Phase 1
• MSLN-targeted CAR-T Cells in Solid Tumors.Not yet recruitingNCT05783089Phase 1
• Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive TumorRecruitingNCT05761366Phase 2
• Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated ProteinsRecruitingNCT05749302Phase 2/3
• Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical ResectionCompletedNCT03575806Phase 2Results posted
• A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal CancerCompletedNCT04207918Phase 2
• A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal CancerStatus unknownNCT03392220Not applicable